NPI: 1659376358 · MEYERSDALE, PA 15552 · Critical Access Hospital · NPI assigned 06/17/2005
Authorized official LAWRENCE, CHARLOTTE controls 20+ related entities in our dataset. Read more
| Authorized Official | LAWRENCE, CHARLOTTE (SECRETARY) |
| NPI Enumeration Date | 06/17/2005 |
Other providers sharing the same authorized official: LAWRENCE, CHARLOTTE
| Year | Claims | Total Paid |
|---|---|---|
| 2020 | 1,429 | $39K |
| 2021 | 11,235 | $292K |
| 2022 | 1,852 | $44K |
| 2023 | 1,431 | $17K |
| 2024 | 974 | $19K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1,082 | 1,013 | $105K |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 997 | 928 | $76K |
| 99284 | Emergency department visit for the evaluation and management, high severity | 337 | 301 | $33K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 254 | 219 | $31K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 226 | 215 | $21K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 986 | 923 | $15K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 947 | 894 | $14K |
| 80053 | Comprehensive metabolic panel | 1,214 | 1,101 | $14K |
| 36415 | Collection of venous blood by venipuncture | 3,695 | 3,089 | $11K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 231 | 221 | $9K |
| 80061 | Lipid panel | 570 | 559 | $8K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 221 | 208 | $8K |
| 80050 | General health panel | 154 | 150 | $8K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 427 | 272 | $7K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1,288 | 1,140 | $7K |
| 84443 | Thyroid stimulating hormone (TSH) | 207 | 196 | $5K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 254 | 239 | $4K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 44 | 40 | $3K |
| 93000 | 193 | 179 | $3K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 76 | 73 | $3K |
| 71046 | Radiologic examination, chest; 2 views | 186 | 167 | $3K |
| 83036 | Hemoglobin; glycosylated (A1C) | 341 | 331 | $2K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 181 | 166 | $2K |
| 80048 | Basic metabolic panel (calcium, ionized) | 317 | 286 | $2K |
| 84484 | 276 | 229 | $2K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 16 | 15 | $2K |
| 83605 | 196 | 178 | $1K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 132 | 121 | $1K |
| 83690 | 205 | 194 | $967.46 | |
| 84439 | 98 | 95 | $897.76 | |
| 71045 | Radiologic examination, chest; single view | 141 | 130 | $880.26 |
| 85027 | 83 | 79 | $725.64 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 97 | 95 | $703.16 |
| 81001 | 244 | 227 | $702.54 | |
| 70450 | Computed tomography, head or brain; without contrast material | 15 | 13 | $611.49 |
| 85610 | 173 | 108 | $610.53 | |
| 84703 | 52 | 51 | $585.01 | |
| 87081 | 85 | 83 | $511.62 | |
| 85379 | 48 | 48 | $509.81 | |
| 81003 | 138 | 130 | $453.03 | |
| 83880 | 14 | 13 | $417.32 | |
| 96361 | Intravenous infusion, hydration; each additional hour | 34 | 29 | $386.19 |
| 87807 | 24 | 23 | $370.21 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 173 | 153 | $313.56 |
| 85730 | 29 | 25 | $169.11 | |
| 96375 | Therapeutic injection; each additional sequential IV push | 32 | 30 | $145.44 |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 12 | 12 | $144.63 |
| 82043 | 16 | 16 | $130.00 | |
| 82570 | 16 | 16 | $116.22 | |
| 82550 | 13 | 13 | $93.62 | |
| 83735 | 15 | 12 | $93.03 | |
| 85651 | 12 | 12 | $39.06 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 74 | 66 | $27.77 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 14 | 12 | $3.64 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 16 | 15 | $0.84 |